ArticleIn vivo (Athens, Greece)
Risk Factors for Sacral Insufficiency Fracture After Pelvic Irradiation for Cervical Cancer.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimSacral insufficiency fracture (SIF) is an important late adverse event after pelvic irradiation for cervical cancer and may impair long-term quality of life. This retrospective study aimed to identify clinical and dosimetric factors associated with SIF after pelvic radiotherapy for cervical cancer. PATIENTS AND
methodsWe analyzed 121 patients treated between 2014 and 2022, including 73 who received curative radiotherapy and 48 who underwent postoperative adjuvant radiotherapy. The sacrum was manually contoured on planning computed tomography (CT), and dose-volume histogram parameters, including mean sacral dose, V30, and V40, were evaluated. Sacral CT attenuation in Hounsfield units (HU) was also measured.
resultsSIF was diagnosed based on follow-up CT, and in patients with SIF, site-specific dose metrics were additionally assessed by fusing planning CT with follow-up CT. SIF occurred in 31 patients (25.6%). In univariate analyses, age ≥55 years, body mass index (BMI) ≤20.5, mean sacral dose ≥38 Gy, and sacral HU <142 were significantly associated with SIF. In multivariate analysis, low BMI and higher mean sacral dose remained independently associated with SIF. Receiver operating characteristic analysis identified 38 Gy as the optimal cut-off value for mean sacral dose in this cohort. Site-specific analysis suggested that fractures tended to occur in relatively high-dose regions within the sacrum.
conclusionLow BMI and higher mean sacral dose were independently associated with SIF after pelvic irradiation for cervical cancer. The 38 Gy threshold and the site-specific dose findings should be considered exploratory and require further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.